PT - JOURNAL ARTICLE AU - Rosa Costa AU - Felipe Bueno AU - Eliseo Albert AU - Ignacio Torres AU - Silvia Carbonell-Sahuquillo AU - Ana Barrés-Fernández AU - David Sánchez AU - Carmelo Padrón AU - Javier Colomina AU - María Isabel Lázaro Carreño AU - José Rafael Bretón-Martínez AU - Cecilia Martínez-Costa AU - David Navarro TI - Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults AID - 10.1101/2021.03.03.21252814 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.03.21252814 4099 - http://medrxiv.org/content/early/2021/03/03/2021.03.03.21252814.short 4100 - http://medrxiv.org/content/early/2021/03/03/2021.03.03.21252814.full AB - Objectives There is limited information comparing SARS-CoV-2 RNA load in the upper respiratory tract (URT) between children and adults, either presenting with COVID-19 or asymptomatic. Here we conducted a retrospective, single center study involving a large cohort of SARS-CoV-2 infected individuals to address this issue.Patients and Methods A total of 1,184 consecutive subjects (256 children and 928 adults) testing positive for SARS-COV-2 RNA in nasopharyngeal exudates (NP) were included, of whom 424 (121 children and 303 adults) had COVID-19 not requiring hospitalization and 760 (135 children and 625 adults) were asymptomatic close contacts of COVID-19 patients. SARS-CoV-2 RNA testing was carried out using the TaqPath COVID-19 Combo Kit (Thermo Fisher Scientific, MS, USA). The AMPLIRUN® TOTAL SARS-CoV-2 RNA Control (Vircell SA, Granada, Spain) was used for estimating SARS-CoV-2 RNA loads (in copies/mL).Results Median SARS-COV-2 RNA loads were comparable between adults and children with COVID-19 (7.14 log10 copies/ml vs. 6.98 log10 copies/ml; P=0.094). Median SARS-CoV-2 RNA load in asymptomatic children and adults was similar (6.20 log10 copies/ml vs. 6.48 log10 copies/ml; P=0.97). Children with COVID-19 symptoms displayed SARS-CoV-2 RNA loads comparable to their asymptomatic counterparts (P=0.61). Meanwhile in adults, median SARS-CoV-2 RNA load was significantly higher in symptomatic than in asymptomatic subjects (P=<0.001), yet comparable (P=0.61) when the analysis excluded patients sampled within 48 h after symptoms onset.Conclusions The data suggest that children may be drivers of SARS-CoV-2 transmission in the general population at the same level as adults.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work received no public or private funds.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The current study was approved by the Research Ethics Committee of Hospital Clinico Universitario INCLIVA (March 2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author, DN.